Press Release: Aeterna Zentaris : Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Company expects to report top-line data and complete study results in Q3 2024
Read full article »
Aeterna Zentaris is a biopharmaceutical company that develops and commercializes drugs for the treatment of orphan endocrine diseases.
Read more